The full filtrate met last week to chat up CREDENCE. Hear the podcast on the web, or subscribe with the following feed link:
http://nephjc.com/freelyfiltered?format=rss
Now with more realistic cover art
This week, we will discuss a phase 2 trial of the TRPC6 inhibitor BI 764198 in FSGS—an early signal for a podocyte-targeted therapy showing proteinuria reduction but set against small numbers, heterogeneity, and methodological trade-offs that frame this as direction-finding rather than definitive evidence.
This week, we will discuss why a large registry cohort was needed to move past decades of scattered case reports and clarify the true risk of hydralazine‑associated vasculitis. When rare events hide in noise, only scale can reveal the signal. Can population‑level data finally bring this paradox into focus?
Summary of the STEPS trial which will be a twitter spaces discussion
This week, we will discuss the HIT trial- a large randomized study challenging one of the most reflexive responses in hospital medicine: see hyponatremia, fix the sodium. But what if correcting the number doesn’t change what actually matters?
The full filtrate met last week to chat up CREDENCE. Hear the podcast on the web, or subscribe with the following feed link:
http://nephjc.com/freelyfiltered?format=rss
Now with more realistic cover art
This visual abstract is by NSMC Intern, Mario Funes
Here is the visual abstract from The George Institue
Omar Taco with a very colorful visual abstract for this week’s discussion of the ASCEND trial of depression on hemodialysis.
Stepping up to the plate is Sinead Stoneman again!
Did you know you can get latest from NephJC in Apple News? Follow this link and enjoy.
Sinead Stoneman did a nice visual abstract for this week’s discussion.
Can you convey the findings of this study in one image? We can definitely try. See this visualization from Divya Bajpai